Unlock new possibilities and drive progress
“We are on the threshold of a new era—where cutting-edge science and AI-driven innovation unlock possibilities once thought impossible.”
— Inspired by Louis Pasteur & John von Neumann
AI/ML Innovations Inc. is a driven team of entrepreneurial technology executives, world-class scientists, AI researchers, and medical experts— all leaders in their fields—who are dedicated to redefining cardiovascular diagnostics through groundbreaking technology.
Our team brings together deep expertise in machine learning, biomedical engineering, and clinical cardiology, enabling us to develop AI-driven ECG solutions that go beyond traditional diagnostics. By harnessing advanced signal processing, predictive analytics, and real-time data interpretation, we are making heart health more accessible, accurate, and proactive.
With our innovative approaches, we aim to bridge the gap between raw biometric data and actionable clinical insights, empowering healhcare professionals with deeper diagnostic precision while giving individuals greater control over their heart health.
Our technology is designed to integrate seamlessly into existing ecosystem of medical systems, wearable devices, and digital health platforms, ensuring that cutting-edge cardiovascular care is available anytime, anywhere.
As we continue to push the boundaries of AI in healthcare, our goal remains clear: to revolutionize the way heart disease is detected, monitored, and prevented—ultimately saving lives on a global scale.
Meet the Team
Paul Duffy
Chief Executive Officer
Paul Duffy brings over 30 years of dynamic leadership and a proven track record in the commercialization of digital technologies. Before joining AI/ML Innovations Inc, Paul was President and Chairman of NexTech3D.AI (CSE: NTAR) and Co-founder and CEO of ARHT Media Inc. (TSXV: ART), where he demonstrated exceptional leadership in inventing, patenting, and commercializing numerous technologies using AI, AR and Holograms. Mr. Duffy's leadership will drive the company’s mission to harness the revolutionary potential of AI and ML in the burgeoning digital health and wellbeing sector and other high growth domains.
Peter Kendall
President and Chief Commercialization Officer
With a distinguished career spanning senior leadership roles at TELUS Health, Medisys, Lifemark, and 3M, Mr. Kendall brings extensive expertise in revenue generation, strategic planning, and team leadership. An accomplished leader in healthcare and technology, Mr. Kendall has consistently driven organizational growth and innovation. His proven ability to scale businesses, cultivate strategic alliances, and optimize operations has made him a transformative force across Canada, the US, and Europe.
Dr. Alan Rabinowitz
Chief Medical Officer and Director of Medical Partnerships
Dr. Alan Rabinowitz was formerly Director of the Coronary Care Unit at St Paul’s Hospital and is currently a cardiologist and Clinical Associate Professor in the Division of Cardiology at St Paul’s Hospital. Alan has held numerous advisory roles to both public and private healthcare entities globally and has also been at the forefront of various entrepreneurial initiatives with a specific focus on disruptive innovation and data innovation in healthcare and the life sciences. Alan received his medical degree from the University of Cape Town, South Africa, completed his internal medicine and cardiology training at the University of Toronto and undertook subsequent training in interventional cardiology at St. Paul’s Hospital, University of British Columbia (“UBC”) in Vancouver, Canada.
Esmat Naikyar
Chief Product Officer
Esmat Naikyar brings a wealth of knowledge and enthusiasm to his role as Interim Chief Product Officer. His background showcases a strong foundation in leading start-ups that pioneer a future where AI and big data converge to transform healthcare through the design and implementation of systems that employ AI for automated decision making. Esmat is at the forefront of guiding AIML's subsidiary, Health Gauge Inc., in the development of advanced Neural Networks, contributing to the ongoing evolution of Artificial Intelligence and Machine Learning applications in healthcare.
Terence Lee
Chief Financial Officer
Terence Lee is a Chartered Professional Accountant (“CPA”) with 11 years of progressive finance experience and in-depth knowledge reporting under International Financial Reporting Standards. Terence has worked in various financial reporting and financial planning roles, for both private and public companies, within various sectors including: Life Sciences, Health Care, Technology, and Mining. Terence holds a Bachelor of Business Administration (finance) from Simon Fraser University and a Diploma of Accounting from UBC. He obtained his CPA designation while articling with BDO Canada LLP where he specialized in financial audits of public companies. Terence is con-currently a partner at Imperium Consulting LLP, a Vancouver-based accounting and advisory firm.
Kendra Low
Corporate Secretary
With more than 20 years’ experience working in corporate and sustainability governance, Kendra is an experienced and respected corporate secretary, governance professional and business strategist. She has advised boards and managed the governance function of publicly traded, private, and not-for-profit organizations through all stages of growth and in a wide variety of industries. She is the CEO of Vancouver Corporate Solutions Inc. and Kalamandra Consulting Inc. Kendra holds a Master of Business Administration (MBA) and a Bachelor of Kinesiology from the University of British Columbia.
Dr. Alan Rabinowitz
Chair of Advisory Board
Dr. Alan Rabinowitz was formerly Director of the Coronary Care Unit at St Paul’s Hospital and is currently a cardiologist and Clinical Associate Professor in the Division of Cardiology at St Paul’s Hospital. Alan has held numerous advisory roles to both public and private healthcare entities globally and has also been at the forefront of various entrepreneurial initiatives with a specific focus on disruptive innovation and data innovation in healthcare and the life sciences. Alan received his medical degree from the University of Cape Town, South Africa, completed his internal medicine and cardiology training at the University of Toronto and undertook subsequent training in interventional cardiology at St. Paul’s Hospital, University of British Columbia (“UBC”) in Vancouver, Canada.
Dr. Paul Dorian
Title Lorem Ipsum Dolor
Dr. Paul Dorian, a distinguished cardiologist and professor at the University of Toronto, has made significant contributions to cardiac electrophysiology, arrhythmia research, and patient care. A former Director of Cardiology at the University of Toronto and President of the Canadian Heart Rhythm Society, he has led groundbreaking clinical trials on sudden cardiac death prevention and treatment. His research has shaped guidelines on atrial fibrillation, heart failure, and sports cardiology, and he has authored over 500 peer-reviewed publications. Dr. Dorian’s expertise in cardiac care, electrophysiology, and healthcare system optimization continues to drive innovation in cardiovascular medicine.
Dr. Marc Deyell
Product Development Advisor, Research & Innovation
Dr. Marc Deyell is the Director of the Heart Rhythm Program at St. Paul’s Hospital in Vancouver, Canada having joined the Heart Rhythm team at St. Paul’s and Vancouver General Hospitals of the UBC Division of Cardiology in 2012. He is also an Associate Professor of Medicine at UBC and an active researcher. His clinical and research interests center around the epidemiology, health outcomes and ablation of arrhythmias, with a focus in ambulatory heart rhythm monitoring and ventricular arrhythmias. He received his medical degree from the University of Alberta. He completed a Masters of Epidemiology at the University of Calgary and his cardiology and electrophysiology training at the University of British Columbia, and undertook an advanced fellowship in Electrophysiology, focused on complex ablation, at the University of Pennsylvania.
Dr. Brett Heilbron
Product Development Advisor
Dr. Brett Heilbron has been based at St. Paul’s Hospital since 1997, where he has a clinical practice and works in the Cardiac Catheterization Laboratory. He is the Medical Director of the Electrodiagnostics program at St. Paul’s, and Mount St. Joseph’s Hospitals, and a Clinical Associate Professor at the University of British Columbia. He is also the Cardiology Consultant for Lifelabs British Columbia. Brett completed his undergraduate degree at the University of Cape Town (South Africa), and then practiced as a rural family physician in Newfoundland and Manitoba for 4 years. He completed Internal Medicine and Cardiology training at UBC in 1995. He has Level 3 Certification in Cardiac Computed Tomography and is a Diplomate of the Certification Board in Cardiac Computed Tomography and a Fellow of the Society of Cardiovascular Computed Tomography.
Dr. David Cramb
Dean, Faculty of Science TMU
Dr. David Cramb is a biophysical chemist for whom the thrill of discovery still runs strong. As Dean of the Faculty of Science at Toronto Metropolitan University since 2018, David is committed to interdisciplinary research and innovative collaborations. As a musician, researcher and teacher in both the arts and sciences, David has led cross-disciplinary teams of researchers in science, medicine, engineering, education and the arts, as well as industrial partners and practicing clinicians. These collaborations have spanned many institutions and crossed borders into the U.S. and Europe. To date, David has secured grants from NSERC, CIHR, CFI and industry partners totalling more than $4 million.
Paul Duffy
Executive Chairman
Paul Duffy brings over 30 years of dynamic leadership and a proven track record in the commercialization of digital technologies. Before joining AI/ML Innovations Inc, Paul was President and Chairman of NexTech3D.AI (CSE: NTAR) and Co-founder and CEO of ARHT Media Inc. (TSXV: ART), where he demonstrated exceptional leadership in inventing, patenting, and commercializing numerous technologies using AI, AR and Holograms. Mr. Duffy's leadership will drive the company’s mission to harness the revolutionary potential of AI and ML in the burgeoning digital health and wellbeing sector and other high growth domains.
Dr. Drew Dundas
Independent
Dr. Dundas brings over two decades of leadership in technology and research, currently serving as Chief Technology Officer at Earlens Corporation, where he leads research and development efforts across various teams, including research, audiology, marketing, and clinical. Prior to Earlens, Dr. Dundas served as President and CTO of Soundhawk Corporation and Director of Audiology at UCSF Medical Center. His background also includes research at Starkey Hearing Technologies, where he contributed to the development of groundbreaking audiological technologies. Dr. Dundas holds a PhD in Audiology & Biomedical Engineering from Vanderbilt University, a Master of Arts from The University of Akron in Audiology, and a BSc from McMaster University. In addition, Dr. Dundas is a fellow of the American Academy of Audiology.
Tim Daniels
Director
Tim Daniels is a seasoned executive with extensive experience in finance and leadership roles within publicly traded companies. He holds a degree in Finance, and has accumulated over 28 years of experience serving as a CEO, CFO, Board member, and Audit Committee member for both public and private organizations. Tim Daniels has a robust background in the development and financing of natural resource, biomedical, and technology companies. Notably, he has been instrumental in the securing of several hundreds of millions of dollars of equity funding for various development stage projects, and previously served in management for a Canadian Investment Dealer, where he gained extensive knowledge in corporate and equity financing, as well as general business development.
Peter Kendall
Director
With a distinguished career spanning senior leadership roles at TELUS Health, Medisys, Lifemark, and 3M, Mr. Kendall brings extensive expertise in revenue generation, strategic planning, and team leadership. An accomplished leader in healthcare and technology, Mr. Kendall has consistently driven organizational growth and innovation. His proven ability to scale businesses, cultivate strategic alliances, and optimize operations has made him a transformative force across Canada, the US, and Europe.